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Abstract
Background: Nursing home residents are at high risk for developing acute illnesses. Compared with
community dwelling adults, nursing home residents are often more frail, prone to multiple medical problems
and symptoms, and are at higher risk for adverse outcomes from acute illnesses. In addition, because of
polypharmacy and the high burden of chronic disease, nursing home residents are particularly vulnerable to
disruptions in transitions of care such as medication interruptions in the setting of acute illness. In order to
better estimate the effect of acute illness on nursing home residents, we have initiated a prospective cohort
which will allow us to observe patterns of acute illnesses and the consequence of acute illnesses, including
symptoms and function, among nursing home residents. We also aim to examine the patterns of medication
interruption, and identify patient, provider and environmental factors that influence continuity of medication
prescribing at different points of care transition.
Methods: This is a prospective cohort of nursing home residents residing in two nursing homes in a
metropolitan area. Baseline characteristics including age, gender, race, and comorbid conditions are recorded.
Participants are followed longitudinally for a planned period of 3 years. We record acute illness incidence and
characteristics, and measure symptoms including depression, pain, withdrawal symptoms, and function using
standardized scales.
Results: 76 nursing home residents have been followed for a median of 666 days to date. At baseline,
mean age of residents was 74.4 (± 11.9); 32% were female; 59% were white. The most common chronic
conditions were dementia (41%), depression (38%), congestive heart failure (25%) and chronic obstructive
lung disease (27%). Mean pain score was 4.7 (± 3.6) on a scale of 0 to 10; Geriatric Depression Scale
(GDS-15) score was 5.2 (± 4.4). During follow up, 138 acute illness episodes were identified, for an
incidence of 1.5 (SD 2.0) episodes per resident per year; 74% were managed in the nursing home and
26% managed in the acute care setting.
Conclusion: In this report, we describe the conceptual model and methods of designing a longitudinal cohort to
measure acute illness patterns and symptoms among nursing home residents, and describe the characteristics of
our cohort at baseline. In our planned analysis, we will further estimate the effect of the use and interruption of
medications on withdrawal and relapse symptoms and illness outcomes.
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Nursing home residents are at high risk for developing
acute illnesses [1,2]. Acute illnesses in older adults often
are associated with complications, such as functional
decline and death [3-5]. Although the consequences of
acute illnesses and hospitalizations among community
dwelling older adults are well described [3-5], less is
known about the consequences of acute illnesses among
nursing home residents. Compared with community
dwelling adults, nursing home residents are often more
frail, prone to multiple medical problems and symp-
toms, and are at higher risk for adverse outcomes from
acute illnesses [1,2].
In the setting of acute illness, because of frailty and
high burden of chronic disease, nursing home residents
are particularly vulnerable to disruptions in transitions
of care such as medication interruptions due to inade-
quate reconciliation [6-8]. In addition, interruption of
medications which act on the central nervous system
(CNS), including opioid analgesics, antidepressants and
antipsychotic medications, confer a risk of adverse with-
drawal events [9-13]. These medications are commonly
used to manage pain, depression, psychosis and other
symptoms among nursing home residents [9-13]. Inter-
ruptions of these medications, which act on the central
nervous system, can lead to withdrawal syndromes,
which often include distressing symptoms such as nau-
sea, vomiting, anxiety, agitation, tremor and restlessness
[14-16].
In order to better estimate the effect of acute illness
on nursing home residents, we have initiated a study
which will allow us to observe patterns of acute illnesses
and the consequence of acute illnesses, including symp-
toms and function, among nursing home residents. We
also aim to examine the patterns of CNS medication
interruption, and identify patient, provider and environ-
mental factors that influence continuity of medication
prescribing at different points of care transition.
Methods
Study Model
We created a conceptual model adapted from the
“Rapid Clinical Decision Making in Context” model
[17], describing factors that may influence clinical deci-
sions in nursing home residents in the setting of acute
illness (AI). We included the following categories of fac-
t o r sa ss h o w ni nF i g u r e1 :p r o v i d e rk n o w l e d g ea n d
experience, patient clinical data, environmental context,
patient expectations and communication. We hypothe-
sized that influential factors vary during the episode
with, for example, illness severity more influential at ill-
ness onset and hospital admission than at hospital dis-
charge, and communication more influential at hospital
admission and discharge than at illness onset. The main
outcomes of acute illness in our model are those that
are clinically important in nursing home patients such
as function change, symptoms (pain, delirium, and med-
ication withdrawal symptoms), and mortality.
Study Design
The study is a prospective observational study of nur-
sing home residents in 2 nursing homes in metropolitan
New York–Jewish Home Lifecare (JHL), New York, NY
and the James J. Peters VA (JJP VA) Community Living
Center (CLC) in Bronx, NY. These nursing homes were
chosen because during acute illness episodes, residents
needing hospital care are referred predominantly to the
Mount Sinai Hospital for JHL residents, and to the
Figure 1 Conceptual Framework: Factors influencing decision whether to continue CNS medication in acutely ill nursing home
residents.
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dents; thus we are able to follow residents at these hos-
pitals, if necessary, during their acute illnesses to
monitor withdrawal of CNS medications and to measure
outcomes.
Eligibility Criteria
Residents are eligible to be enrolled in the study if they
are receiving opioids, antidepressants, or antipsychotics
on a routine basis for a duration of time considered to
be a minimal therapeutic trial or in which tolerance
develops. Because of the differences in pharmacoki-
netics and biologic effects among the 3 drug classes, a
minimal therapeutic trial of 14, 30 and 7 days was
selected for opioids, antidepressants, and antipsychotics
respectively. We are including residents taking more
than one medication in a class, or more than one class
of medication if there are no known interactions
between the medications. We are excluding residents
receiving antidepressants who score fewer than 21
points on the Mini-Mental Status Examination [18]
because the assessment of symptoms of depression,
which is a main outcome, among those with more
severe degrees of dementia, is less reliable. We are
excluding residents who have an acute medical illness
(defined below) at the time of screening and rescreen-
ing them for enrollment after it has resolved. Informed
consent is obtained from residents or proxies. The
study was approved by the Institutional Review Board
at JHL and JJP VA Medical Center.
Acute Illness Surveillance and Points of Care Transition
Acute illness surveillance is performed twice weekly at
the nursing home through communication with nursing
home nursing staff and medical providers using estab-
lished clinical criteria [19] for incipient cases. The clini-
cal criteria for acute illness are meant to be sensitive for
all acute medical problems experienced by nursing
home residents and include clinical symptoms such as
chest pain, dyspnea, diarrhea, acute change in mental
status; clinical signs such as persistent increase or
decrease in blood pressure, f e v e ro rh y p o t h e r m i a ;a n d
abnormalities in laboratory values such as a drop in
hematocrit > 5 points with signs of acute bleeding. We
follow patients for 14 days after illness onset, and if
applicable, an additional 14 days each after hospital
admission and hospital discharge. During each follow-up
interval we assess the following signs and symptoms by
patient and staff interview in the nursing home or in the
hospital: pain, delirium, and withdrawal symptoms
including gastrointestinal and cardiopulmonary signs
and symptoms three times weekly, and mood and beha-
vior once weekly, using validated instruments adapted
for this population described below.
Measures
Baseline demographic information including age, gender,
and race of each participant is collected. In addition, at
baseline we collect information on chronic medical con-
ditions and medication use through medical record
abstraction, and on physical and cognitive function by
interviews with patients, or proxies, and nursing home
staff. Functional status is measured using items from the
Minimum Data Set Activities of Daily Living Scale
(MDS-ADL) adapted for interview with nursing home
staff [20]. The MDS-ADL scale ranges from 0 to 6 with
higher scores indicating poorer functional status. Cogni-
tive function is measured using items from the Mini-
mum Data Set Cognitive performance scale (MDS-CPS)
[21] adapted for interview with nursing home staff and
from the Mini Mental Status Examination (MMSE) [18].
Illness severity is measured using a physiologic measure,
the Inpatient Physiologic Failure Score (IPFS) [22],
which is adapted and validated for use in the elderly
population. In the setting of acute illness, participants
are assessed for delirium using the Confusion Assess-
ment Method (CAM) [23].
Withdrawal symptoms from opiate withdrawal are
measured using the Clinical Opiate Withdrawal Scale
(COWS) [24], which contains measurements of several
common signs and symptoms of withdrawal including
tachycardia, sweating, restlessness, tremor, yawning,
anxiety or irritability, gastrointestinal upset, pupil dila-
tion, gooseflesh skin, running nose or tearing, and bone
or joint aches. Scores on this scale vary from 0 to 48
with higher scores indicating more severe withdrawal.
Withdrawal symptoms from antidepressants are mea-
sured using the Discontinuation Emergent Signs and
Symptoms (DESS) scale [25]. We modified the scale to
include only items within the proposed diagnostic cri-
teria for Serotonin Reuptake Inhibitor syndrome [26],
which includes the following symptoms–headache,
insomnia, irritability, anxiety, fatigue, paresthesias,
tremors, visual changes, dizziness, nausea, diarrhea,
stomach cramps, chills, flushing and gait instability.
We classify delirium as a separate complication from
withdrawal, although we consider it consistent with
withdrawal.
Relapse symptoms such as depression, psychosis and
pain are measured using standardized instruments.
Depression is measured using the Geriatric Depression
Scale (GDS) [27], a 15-point scale for measuring depres-
sion in the elderly; a score of 5 or above indicates a
positive screen for depression. Psychosis and disturbed
behavior are measured using the Cohen Mansfield Agi-
tation Inventory (CMAI) [28]. This scale contains 29
behaviors including verbal and physical behaviors, exam-
ples of which are repetitiveness, screaming, verbal
aggression, and wandering. On the scale, these behaviors
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Scores range from 29 to 103, with higher scores indicat-
ing more agitation. We used this scale as a measure-
ment of the effect of antipsychotic cessation, because
antipsychotic withdrawal has been associated with
relapse symptoms [29], which can be reliably measured
using this scale.
Pain is measured using a variety of measures based on
whether the participant can reliably indicate their pain
and severity. For participants who can indicate their
pain, a modified Brief Pain Inventory (BPI) [30] is used,
which measures the location and the severity of pain
experienced currently and also in the past 24 hours. Par-
ticipants are also asked to indicate how much their pain
has interfered with their mood, sleep, walking ability
and other activities. If the participant is unable to com-
plete the BPI, a McGill Present Pain Intensity Scale [31]
from 0 to 5 is attempted, and if unable to complete this,
the participant is asked if they have pain currently (yes/
no). If the participant is unable to provide answers
regarding their pain, the checklist of nonverbal pain
indicators (CNPI) [32] is used. Nursing staff are asked if
they have observed any vocal complaints including
verbal complaints and non-verbal sounds such as moans
or groans, facial grimaces, restlessness, bracing, and
rubbing during activity or rest.
Because symptoms of relapse and withdrawal can
occur acutely and resolve in a short period of time, the
pain, Clinical Opiate Withdrawal Scale (COWS), and
Discontinuation Emergent Signs and Symptoms (DESS)
scale are repeated three times a week during AI episodes
to determine if withdrawal symptoms occurred. Func-
tional status data are collected at the time of enrollment,
subsequently at 3-month intervals and at the time of ill-
ness onset and 14 days after illness. Figure 2 outlines
the timeline of our data collection during the study
period.
Statistical Analysis
Baseline demographic characteristics and symptoms
measured on scales described above are summarized
using descriptive statistics. Characteristics of acute ill-
ness including illness type and severity, are described.
Planned analyses include estimation of the effect of
acute illness on functional decline by comparing magni-
tude of functional change during periods with acute ill-
ness with periods without acute illness. Additional
analyses include a description of the pattern of interrup-
tion of CNS medications during the acute illness and, to
examine predictors of CNS medication interruption,
estimation of a multivariable logistic regression model
using occurrence of interruption in CNS medication as
dependent variable, and patient, illness, and provider
characteristics as independent variables. We will select
independent variables to include in the model based on
whether a factor is associated with the outcome in
univariate analysis.
To examine the impact of CNS medication interrup-
tion on patient outcomes, we plan to estimate multivari-
able logistic regression models with pain, depression
and disturbed behavior at the moderate or severe level
as dependent variables and interruption in CNS medica-
tions as independent variable. Covariates will include
Figure 2 Timeline of Assessments of Participants.
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Furthermore, we plan to describe the effect of the inter-
ruption of CNS medications on hospital use, illness
duration and functional outcomes, using similar multi-
variable regression models.
We also plan to compare proportions of patients who
developed withdrawal symptoms who had medication
interruption to those who did not have medication
interruption. For the sample size of 200 AI episodes, we
estimated that 20% of them would have an interruption
of CNS medications. Assuming that the proportion who
would have withdrawal symptoms without interruption
of CNS medications (due to other causes such as the
acute illness itself) to be 15%, this will provide 83%
power (with an alpha of 0.05) to detect an absolute
difference of 25% in the proportion with interruption of
CNS medications who develops withdrawal symptoms
(with a proportion of 40%). To estimate the effect of
acute illness on function, we collected functional status
data at the time of enrollment, subsequently at 3 month
intervals, and at the time of illness onset and 14 days
after illness. We plan to use a linear mixed model to
account for such repeated measurements.
Results
Baseline characteristics of study participants are
summarized in Table 1. Overall, 76 residents have been
recruited for the study, including 46 from JJP VA and
30 from JHL. Average age at enrollment was 69 years
(SD 11) at VA and 80 (SD 9) at JHL. Overall 32% were
female; however, this varied by site with 77% female at
JHL and 2% female at JJP VA. Overall 25% were
Black and 12% Hispanic. The most common chronic
conditions were dementia (N = 31, 41%) and depression
(N = 30, 38%). Other common conditions included
congestive heart failure (25%), chronic obstructive lung
disease (27%) and stroke (15%). Median duration of stay
in the nursing home prior to enrollment was 153 days,
with an interquartile range of 55 and 563 days. The
mean number of hospitalization episodes in the year
prior to enrollment was 1.2 episodes per resident
(SD 1.1). Mean number of medications taken was 7.6
(SD 3.2). A quarter of study participants were taking
antidepressants only, 17% were taking antipsychotic
medications only, and 33% were taking opioid medica-
tions only. 25% of residents were taking more than one
class of CNS medications; the most frequent combina-
tions were an antidepressant and an opioid medication
(14%), followed by a combination of an antidepressant
and an antipsychotic medication (7%). Average function
score on the MDS scale was 2.3 (SD 2.1), which corre-
sponds to a functional status which requires limited
assistance in ADL activities. Average GDS score was 5.2
(SD 4.4); 47% had a score of 5 or higher indicating a
positive screen for depression. Average pain score was
4.7 (SD 3.6), which corresponds to moderate pain; and
6 2 %o fr e s i d e n t sr e p o r t e dt h a tt h e yh a v em o d e r a t eo r
severe pain. Average CMAI score was 35.8 (SD 8.1);
29% had a score of 39 or over, which indicates frequent
and severe agitation.
With a median follow up time of 666 days, to date we
have observed a total of 138 acute illness episodes, for
an incidence of 1.5 (SD 2.0) episodes per resident per
year, 74% of which were managed in the nursing home
Table 1 Baseline characteristics of nursing home







Age (mean (SD)) 74.4 (11.9) 69.4 (10.8) 82.0 (9.4)
Female 31.6 2.2 76.7
Race
White 57.9 45.7 76.7
Black 29.0 43.5 6.7
Hispanic 11.8 10.9 13.3
Comorbid Conditions (%)
CHF 25.0 17.4 36.7
COPD 27.6 32.6 20.0
Stroke 15.8 15.2 16.7
Dementia 40.8 21.7 70.0
Depression 38.2 37.0 26.7
Falls 52.6 41.3 70.0
Medications (total no. ± SD) 7.6 ± 3.2 8.0 ± 3.6 6.8 ± 2.6
CNS Medications (%)
Antidepressants 25 22 30
Anti-psychotic medications 17 17 17
Opioids 33 30 37
Any combination of 2 or more 25 30 16
Duration of NH residence







Number of hospitalization in the
year prior to enrollment ± SD
1.2 ± 1.1 1.5 ± 1.2 0.7 ± 0.5
Number of acute illness episodes
(per resident per year)
1.5 ± 2.0 1.7 ± 2.2 1.0 ± 1.3
Function (MDS-ADL) 2.3 ± 2.1 2.2 ± 2.3 2.4 ± 2.0
Cognitive function (MDS-CPS) 1.1 ± 1.6 1.0 ± 1.8 1.3 ± 1.5
Depression (GDS-15) 5.2 ± 4.4 5.5 ± 4.4 4.8 ± 4.5
Pain (0-10 scale) 4.7 ± 3.6 5.5 ± 3.3 3.4 ± 3.7
Psychosis and disturbed
behavior (CMAI)
35.8 ± 8.1 35.9 ± 7.9 35.7 ± 8.6
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Table 2. Residents managed in the nursing home tended
to be less ill, with a mean IPFS score of 1.5, compared
with those managed in the hospital, with an IPFS of 5.3
(p < 0.001). The most common diagnoses of AI mana-
ged in the NH were urinary tract infection and cellulitis,
whereas the most common diagnoses in the hospital set-
ting were cardiac causes (such as congestive heart failure
or myocardial infarction) and pneumonia.
Discussion
In this paper we describe an ongoing longitudinal
cohort study designed to measure symptoms and func-
tion change in nursing home patients with acute illness,
to observe the continuity of CNS medication use for
depression, pain and psychosis, and the consequence of
CNS medication interruptions among nursing home
residents in the setting of acute illness. Using our data
thus far, we found that symptom burdens in our study
cohort at baseline were high despite treatment. About
two thirds of the study cohort had moderate or severe
pain at baseline; close to half screened positive for
depression; and 29% likely had clinically relevant
agitation. Although our high rates may reflect our
patient selection, it also likely reflects that symptoms
persist despite treatment, and that nursing home
residents with depression, pain and agitation may be
under-treated. In addition, correlating with prior research
[1], we confirmed that the majority of acute illnesses
(74%) among nursing home residents were treated in the
nursing home rather than in the acute care setting. Not
surprisingly, acute illnesses of higher severity and spec-
trum were treated in the hospital compared with those
treated in the nursing home setting. We have planned
further analysis to address several other research ques-
tions pertaining to clinical decision making, health ser-
vices and outcomes. Table 3 highlights the research
questions we plan to address using our cohort design.
Our study also highlights some methodological
features which may be utilized by other investigators
designing similar studies in this population. In order to
determine the impact of acute illness, the research team
actively surveys for the occurrence of acute illness. Pre-
vious studies relying on medical records or referrals
from providers are likely to miss acute illnesses which
are less severe or are treated in the nursing home set-
ting. Because reliable reports of symptoms such as pain,
delirium, and withdrawal symptoms require real-time
ascertainment, the active surveillance by the research
team is essential to capture acute illnesses and symp-
toms prospectively. In addition, because transitions of
care across multiple settings occur in nursing home resi-
dents experiencing acute illnesses, it is essential for the
research team to conduct symptom monitoring in these
different settings. Symptoms are assessed frequently in
this study because symptoms of withdrawal can occur
acutely and resolve in a short period of time.
Furthermore, the choice of the two nursing homes in
our study also allows us to examine the effect of an inte-
grated medical system with electronic medical record
sharing on medication interruption and continuity of
care. Medication and treatment information is readily
available across nursing home and hospital settings





Number of Acute Illness
Episodes
102 (74%) 36 (26%)
IPFS score (SD), Illness Severity 1.5 (2.5) 5.3 (4.2)
AI characteristics









Table 3 List of research questions potentially addressed in this cohort study
A. Health services and quality of care
1. Among nursing home residents, what is the impact of acute illness, managed at the nursing home or in the hospital, on patient outcomes
including function and mortality?
2. What is the impact of acute illness on symptoms such as pain, depression, agitation?
3. What is the effect of acute illness on functional status, which is a publicly-reported measure of nursing home quality?
4. How often are CNS medications interrupted during care transition periods and what are the factors affecting the pattern of medication
interruption?
B. Clinical decision
1. What is the balance of benefit and risk of holding opiates and other CNS medications during acute illness episodes?
C. Epidemiology
1. What is the longitudinal symptom burden, including pain, depression, agitation and others, among nursing home residents?
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VA-based nursing home. On the other hand, JHL does
not have an integrated electronic system. Therefore, pro-
viders rely on traditional methods of communication
using transition documents or telephone communication.
A limitation of our study is that our examination of
different levels of factors affecting medication interrup-
tion is limited by the proportion of AI with medication
interruption. The analysis of the effects of multiple fac-
tors may require a larger sample size. However, we will
likely be able to observe clinically important effects that
are of larger magnitude. In addition, considering the
two cohorts included in the sample, there were signifi-
cant differences in the characteristics of the VA cohort
compared with the JHL cohort. The VA cohort was
younger, more likely to be male, black and less likely to
have dementia. The different characteristics of the VA
cohort may limit generalizability to community nursing
homes, but the inclusion of the VA cohort also help
complement the gender and racial makeup of the study
sample.
Conclusions
In this paper, we described the methods of our study in
detail and our cohort characteristics. The aim of our
study is to inform nursing home physicians the effect of
acute illness on symptoms, function change and medica-
tion use in nursing home residents. Considering that
nursing home residents are likely to have high symptom
burden, and to be vulnerable to acute illness and to dis-
ruptions in care across care settings, the study has the
potential to improve the care of nursing home residents
across care settings.
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